Article

Effectiveness of a Risk Screener in Identifying Hepatitis C Virus in a Primary Care Setting

Mari-Lynn Drainoni, Elisa A. Koppelman, and Cindy L. Christiansen are with the Department of Health and Policy Management, Boston University School of Public Health, Boston, MA. Alain H. Litwin is with the Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY. Bryce D. Smith and Cindy M. Weinbaum are with the Division of Viral Hepatitis, National Center for HIV/Viral Hepatitis/STD/TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA. M. Diane McKee is with the Department of Family Medicine, Albert Einstein College of Medicine and Montefiore Medical Center. Allen L. Gifford is with the VA HIV/Hepatitis Quality Enhancement Research Initiative, Edith Nourse Rogers Memorial Veterans Administration Hospital, Bedford, MA. William N. Southern is with the Division of Hospital Medicine, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center.
American Journal of Public Health (Impact Factor: 4.55). 09/2012; 102(11):e115-e121. DOI: 10.2105/AJPH.2012.300659
Source: PubMed

ABSTRACT

Objectives:
We evaluated an intervention designed to identify patients at risk for hepatitis C virus (HCV) through a risk screener used by primary care providers.

Methods:
A clinical reminder sticker prompted physicians at 3 urban clinics to screen patients for 12 risk factors and order HCV testing if any risks were present. Risk factor data were collected from the sticker; demographic and testing data were extracted from electronic medical records. We used the t test, χ(2) test, and rank-sum test to compare patients who had and had not been screened and developed an analytic model to identify the incremental value of each element of the screener.

Results:
Among screened patients, 27.8% (n = 902) were identified as having at least 1 risk factor. Of screened patients with risk factors, 55.4% (n = 500) were tested for HCV. Our analysis showed that 7 elements (injection drug use, intranasal drug use, elevated alanine aminotransferase, transfusions before 1992, ≥ 20 lifetime sex partners, maternal HCV, existing liver disease) accounted for all HCV infections identified.

Conclusions:
A brief risk screener with a paper-based clinical reminder was effective in increasing HCV testing in a primary care setting.

Download full-text

Full-text

Available from: Bryce David Smith
  • Source
    • "In this issue, Meyer et al. performed a systematic review of evidence-based strategies to enhance HCV diagnosis/testing, linkage to HCV care, HCV treatment and viral cure (including enhanced adherence) (Meyer, this issue). Successful strategies to increase HCV testing and diagnosis include interventions based on targeted case-finding (Cullen et al., 2012), risk-based assessment (Drainoni et al., 2012; Litwin et al., 2012), birth-cohort screening (Litwin et al., 2012), and motivational interviewing with case management (Masson et al., 2013). Enhanced screening could also be achieved through targeted HCV testing initiatives such as free counselling and testing, point-ofcare testing, and dried blood spot testing (Meyer, this issue). "

    Full-text · Article · Jul 2015 · The International journal on drug policy
  • Source
    • "In this issue, Meyer et al. performed a systematic review of evidence-based strategies to enhance HCV diagnosis/testing, linkage to HCV care, HCV treatment and viral cure (including enhanced adherence) (Meyer, this issue). Successful strategies to increase HCV testing and diagnosis include interventions based on targeted case-finding (Cullen et al., 2012), risk-based assessment (Drainoni et al., 2012; Litwin et al., 2012), birth-cohort screening (Litwin et al., 2012), and motivational interviewing with case management (Masson et al., 2013). Enhanced screening could also be achieved through targeted HCV testing initiatives such as free counselling and testing, point-ofcare testing, and dried blood spot testing (Meyer, this issue). "

    Full-text · Article · Jul 2015 · The International journal on drug policy
  • Source
    • "Importantly, other community based organizations, such as opioid treatment centers and urban primary care clinics, have been shown to increase HCV testing rates in high prevalence populations [26-28]. These community-based settings are unique in that, not only are they able to establish HCV positivity through screening programs, they are often able to offer HCV care and medical therapy, taking advantage of an already engaged at-risk population. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In an attempt to curtail the rising morbidity and mortality from undiagnosed HCV (hepatitis C virus) in the United States, screening guidelines have been expanded to high-risk individuals and persons born 1945-1965. Community-based screening may be one strategy in which to reach such persons; however, the acceptance of HCV testing, when many high-risk individuals may not have access to HCV specific medications, remains unknown. We set out to assess attitudes about HCV screening and knowledge about HCV disease at several community-based testing sites that serve high-risk populations. This assessment was paired with a brief HCV educational intervention, followed by post-education evaluation. Participants (n = 140) were surveyed at five sites; two homeless shelters, two drug rehabilitation centers, and a women's "drop-in" center. Personal acceptance of HCV testing was almost unanimous, and 90% of participants reported that they would still want to be tested even if they were unable to receive HCV treatment. Baseline hepatitis C knowledge was poor; however, the brief educational intervention significantly improved knowledge and increased acceptability of testing when medical access issues were explicitly stated. Despite inconsistencies in access to care and treatment, high-risk communities want to know their HCV status. Though baseline HCV knowledge was poor in this population, a brief on-site educational intervention improved both knowledge and acceptability of HCV testing and care. These data support the establishment of programs that utilize community-based screening, and also provide initial evidence for acceptance of the implementation of the recently expanded screening guidelines among marginalized communities.
    Full-text · Article · Feb 2014 · BMC Infectious Diseases
Show more